Brenntag Opens New Head Office in India
News Feb 21, 2012
Brenntag has inaugurated its new head office in Mumbai, India. This new office represents Brenntag’s continued commitment to invest in India and to ensure the company has ample room for its planned growth over the next few years.
Brenntag established its presence in India in 2008 and focuses on various industry segments such as Agro, Coatings, Food & Beverage, Leather, Lubricants, Personal Care, Pharmaceuticals, Plastics & Polymers, Polyurethanes, Solvents and Textile.
The new office adds to the company’s six existing offices located in all major industrial locations in India and Brenntag’s growing presence in the Asia Pacific region, which includes more than 40 offices in 15 countries.
At the inauguration of the new office, Steven Holland, CEO of Brenntag Group, said, “India is a key market in Brenntag’s global strategy. By expanding our local presence in major cities like Mumbai, we are supporting our strategy of being the leading chemical distributor in both specialty and industrial chemicals. We already have a strong foothold in India and we expect to take advantage of the high growth potential in the Indian market.”
With in-house Food & Beverage and Personal Care technical application laboratories, the new office offers value-added services to Brenntag’s customers by meeting specific requirements for the formulation and customization of various blends of ingredients and chemicals.
Like all of Brenntag’s offices, compliance with local as well as international standards on health, safety and the environment at the workplace is a priority.
The new head office is centrally located at Ackruti Centre Point, Andheri (East), Mumbai. It has a space area covering 15,000 sq. ft. and will have room for more than 100 employees.
At present, there are 44 employees based at the new office. In addition, Brenntag has offices and distribution facilities in Baddi, Bengaluru, Chennai, Gurgaon, Haridwar and Hyderabad.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE